| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |